NCT06817642

Brief Summary

Introduction: Stroke affects one person every 4 minutes in France (i.e. more than 140,000 new cases per year) resulting in cognitive and motor disorders. Aphasia is one of the most devastating cognitive disorders that persist in the late phase. However, early treatment of aphasia can improve the effects of rehabilitation. Identifying, as early as possible, the patients most at risk of presenting persistent language disorders in the late phase would make it possible to improve their management and increase the effects of cognitive rehabilitation on their language abilities. The aim of this project is to evaluate whether the Core Assessment of Language Processing (CALAP) assessed in the acute phase of stroke can predict language abilities in the late phase. Hypothesis/Objective: The primary objective is to determine whether the language abilities of patients in the acute phase of stroke can be used to predict language abilities in the late phase. Secondary objectives are to determine whether prediction can be improved with (1) brain MRI data and (2) neuropsychological assessment data. The (3) secondary objective is to determine whether cognitive abilities at the chronic phase can be predicted by language performance in the acute phase. The (4) secondary objective is to assess whether language rehabilitation modifies the predictive power of the language abilities assessed with the CALAP. Method: Patients will be included during their hospitalization after a brain vascular injury (acute phase, up to 21 days of hospitalization). After discharge, they will return for a post-stroke assessment between 3 and 18 months after the acute phase. During these two visits, a clinical and neurological examination, a neuropsychological assessment and an MRI will be performed. A prediction model (development and validation) will be used for all objectives using a linear regression model with cross validation. The entire sample consists of stroke patients. The study is single-center and will have a total duration of 6 years with an estimated 570 patients included. Conclusion: Predicting the language abilities of a post-stroke patient will improve clinical management and direct patients requiring language rehabilitation to appropriate care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
570

participants targeted

Target at P75+ for all trials

Timeline
43mo left

Started Jan 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Jan 2023Dec 2029

Study Start

First participant enrolled

January 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 5, 2023

Completed
1.6 years until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2029

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

June 4, 2025

Status Verified

February 1, 2025

Enrollment Period

6.5 years

First QC Date

July 5, 2023

Last Update Submit

May 30, 2025

Conditions

Keywords

StrokeAphasiaLanguage abilitiesCognitive abilitiesPrediction of function recovery

Outcome Measures

Primary Outcomes (1)

  • Language recovery prediction with Core Assessment of Language Processing score

    the objective is to predict from stroke patient's language performance in the acute phase, his or her language performance in the late phase

    18 months after stroke

Secondary Outcomes (4)

  • Improving CALAP recovery prediction using MRI data

    18 months after stroke

  • Improving CALAP recovery prediction using neuropsychological data

    18 months after stroke

  • Cognitive recovery prediction with Core Assessment of Language Processing score

    18 months after stroke

  • Improving CALAP recovery prediction using language rehabilitation data

    18 months after stroke

Interventions

Data recovery from language assessment: Core Assessment of LAnaguage Processing, and from neuropsychological assessment : Montreal Cognitive Assessment, Trail Making Test, Batterie Rapide d'Efficience Frontale (BREF), animal fluency, 5 words of Dubois, Ne

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Stroke patients (hemispheric stroke, ischemic or hemorrhagic).

You may qualify if:

  • Age: between 18 and 85 years old
  • Inpatient in the initial phase of stroke (between 0 and 21 days after stroke)
  • Hemispheric stroke, ischemic or haemorrhagic
  • Ability to participate in tests
  • Francophone
  • ≤ NIHSS score ≤21 or if NIHSS score \< 4, LAST score \[0-13\]
  • Non-opposition to participation in tests

You may not qualify if:

  • Severe alertness impairment incompatible with test participation, NIHSS score 1a. different from 0
  • Severe overall intellectual deterioration incompatible with test participation
  • Patients who may have a visual or hearing impairment incompatible with participation in CALAP
  • History of stroke
  • Posterior fossa stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hôpitaux de Paris - Hôpital Henri Mondor

Créteil, 94010, France

RECRUITING

MeSH Terms

Conditions

StrokeAphasia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSpeech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Anne-Catherine BACHOUD-LEVI, MD, PhD

CONTACT

Tiffany MONNIER, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2023

First Posted

February 10, 2025

Study Start

January 1, 2023

Primary Completion (Estimated)

June 30, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

June 4, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations